ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer
to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there
be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the
requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Additional Information about the Merger and Where to Find It
In connection with the proposed transaction, Cabot filed with the SEC
a registration statement on Form S-4 on June 29, 2021, that includes a preliminary joint proxy statement of Cabot and Cimarex and that
also constitutes a preliminary prospectus of Cabot. If and when the registration statement becomes effective and the joint proxy statement/prospectus
is in definitive form, such joint proxy statement/prospectus will be sent to the stockholders of Cabot and Cimarex. Each of Cabot and
Cimarex also intends to file other relevant documents with the SEC regarding the proposed transaction, including the definitive joint
proxy statement/prospectus. The information in the preliminary joint proxy statement/prospectus is not complete and may be changed. This
communication is not a substitute for the preliminary joint proxy statement/prospectus or registration statement or any other document
that Cabot or Cimarex may file with the SEC. The definitive joint proxy statement/prospectus (if and when available) will be mailed to
stockholders of Cabot and Cimarex. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PRELIMINARY JOINT
PROXY STATEMENT/PROSPECTUS, THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS IF AND WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS
THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY
CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CABOT, CIMAREX AND THE PROPOSED TRANSACTION. Investors and security holders are able
to obtain free copies of the registration statement and preliminary joint proxy statement/prospectus and all other documents containing
important information about Cabot, Cimarex and the proposed transaction, once such documents are filed with the SEC, including the definitive
joint proxy statement/prospectus if and when it becomes available, through the website maintained by the SEC at http://www.sec.gov. Copies
of the documents filed with the SEC by Cabot may be obtained free of charge on Cabot’s website at www.cabotog.com/investor-relations
or by contacting Matt Kerin by email at matt.kerin@cabotog.com or by phone at 281-589-4642. Copies of the documents filed with the SEC
by Cimarex may be obtained free of charge on Cimarex’s website at www.cimarex.com/investor-relations.
Participants in the Solicitation
Cabot, Cimarex and certain of their respective directors and executive
officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about the
directors and executive officers of Cabot, including a description of their direct or indirect interests, by security holdings or otherwise,
is set forth in Cabot’s proxy statement for its 2021 Annual Meeting of Stockholders, which was filed with the SEC on March 12, 2021,
and Cabot’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on February 26,
2021. Information about the directors and executive officers of Cimarex, including a description of their direct or indirect interests,
by security holdings or otherwise, is set forth in Cimarex’s proxy statement for its 2021 Annual Meeting of Stockholders, which
was filed with the SEC on March 26, 2021, and Cimarex’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020,
which was filed with the SEC on February 23, 2021. Investors may obtain additional information regarding the interests of those persons
and other persons who may be deemed participants in the proposed transaction by reading the preliminary joint proxy statement/prospectus,
including any amendments thereto, as well as the definitive joint proxy statement/prospectus if and when it becomes available and other
relevant materials to be filed with the SEC regarding the proposed transaction when such materials become available. Investors should
read the preliminary joint proxy statement/prospectus, and the definitive joint proxy statement/prospectus if and when it becomes available,
carefully before making any voting or investment decisions. You may obtain free copies of these documents from Cabot or Cimarex using
the sources indicated above.
Cautionary Statement Regarding Forward-Looking Information
This communication contains certain forward-looking statements within
the meaning of federal securities laws. Words such as anticipates, believes, expects, intends, plans, outlook, will, should, may and similar
expressions may be used to identify forward-looking statements. Forward-looking statements are not statements of historical fact and reflect
Cabot’s and Cimarex’s current views about future events. Such forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving Cabot and Cimarex, including future financial and operating results;
Cabot’s and Cimarex’s plans, objectives, expectations and intentions; the expected timing and likelihood of completion
of the transaction; the expected timing and amount of any future dividends; and other statements that are not historical facts,
including estimates of oil and natural gas reserves and resources, estimates of future production, assumptions regarding future oil and
natural gas pricing, planned drilling activity, future results of operations, projected cash flow and liquidity, the achievement of synergies,
business strategy and other plans and objectives for future operations. No assurances can be given that the forward-looking statements
contained in this communication will occur as projected and actual results may differ materially from those projected. Forward-looking
statements are based on current expectations, estimates and assumptions that involve a number of risks and uncertainties that could cause
actual results to differ materially from those projected. These risks and uncertainties include, without limitation, the ability to obtain
the requisite Cabot and Cimarex stockholder approvals; the risk that Cabot or Cimarex may be unable to obtain governmental and regulatory
approvals required for the merger; the risk that an event, change or other circumstances could give rise to the termination of the
proposed merger; the risk that a condition to closing of the merger may not be satisfied on a timely basis or at all; the length
of time necessary to close the proposed transaction, which may be longer than anticipated for various reasons; the risk that the
businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not
be fully realized or may take longer to realize than expected; the risk that any announcement relating to the proposed transaction
could have adverse effects on the market price of Cabot’s common stock or Cimarex’s common stock; the risk of litigation
related to the proposed transaction; the effect of future regulatory or legislative actions on the companies or the industry in which
they operate, including the risk of new restrictions with respect to well spacing, hydraulic fracturing, natural gas flaring or other
oil and natural gas development activities; the risk that the credit ratings of the combined business may be different from what
the companies expect; disruption from the transaction making it more difficult to maintain relationships with customers, employees
or suppliers; the diversion of management time on merger-related issues; the volatility in commodity prices for crude oil and
natural gas; the continuing effects of the COVID-19 pandemic and the impact thereof on Cabot’s and Cimarex’s businesses,
financial condition and results of operations; actions by, or disputes among or between, the Organization of Petroleum Exporting
Countries and other producer countries; the presence or recoverability of estimated reserves; the ability to replace reserves;
environmental risks; drilling and operating risks; exploration and development risks; competition; the ability of
management to execute its plans to meet its goals; and other risks inherent in Cabot’s and Cimarex’s businesses. In addition,
the declaration and payment of any future dividends, whether regular base quarterly dividends, variable dividends or special dividends
following completion of the proposed transaction, will depend on the combined business financial results, cash requirements, future prospects
and other factors deemed relevant by the board of directors of Cabot (as then constituted). These risks, as well as other risks related
to the proposed transaction, are described in the registration statement on Form S-4 and preliminary joint proxy statement/prospectus
that was filed with the SEC and the definitive joint proxy statement/prospectus if and when it becomes available in connection with the
proposed transaction. While the list of factors presented here is, and the list of factors to be presented in the registration statement
on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties.
Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may
vary materially from those indicated. For additional information about other factors that could cause actual results to differ materially
from those described in the forward-looking statements, please refer to: (1) Cabot’s annual reports on Form 10-K, quarterly reports
on Form 10-Q and current reports on Form 8-K, which are available on Cabot’s website at www.cabotog.com/investorrelations and on
the SECs website at http://www.sec.gov; and (2) Cimarex’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current
reports on Form 8-K, which are available on its website at www.cimarex.com/investor-relations and on the SECs website at http://www.sec.gov.
Forward-looking statements are based on the estimates and
opinions of management at the time the statements are made. Except to the extent required by applicable law, neither Cabot nor
Cimarex undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new
information, future events or otherwise. Readers are cautioned not to place undue reliance on these forward-looking statements that
speak only as of the date hereof.
